Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 70 (RPSAP70) is a member of the RPSA pseudogene family, representing a non-functional, non-protein-coding duplicate of the functional ribosomal protein SA (RPSA) gene. Pseudogenes like RPSAP70 generally do not code for functional proteins and typically have no direct molecular or biological role. While the functional RPSA gene encodes a protein involved in ribosome function, cell adhesion, and pathologies such as cancer and prion diseases, RPSAP70 itself is not known to participate in these processes or act as a drug target. There is no evidence that RPSAP70 serves as a therapeutic or diagnostic target, or is associated with any disease roles. RPSAP70 is classified as a processed pseudogene of ribosomal protein SA (RPSA). The RPSA gene family contains a single active gene and numerous pseudogenes, most of which are non-functional and not transcribed or translated. Most functional studies, therapeutic interest, and disease associations pertain to RPSA (not pseudogenes), which acts as a ribosomal protein, laminin receptor, and is involved in various diseases such as cancer and prion disease. There is no evidence that RPSAP70 is itself functional, expressed, or involved in human disease, drug interactions, or patient selection. It does not encode a known protein product, nor is it established as a target in therapeutic development. The term “pseudogene” in this context specifically means a DNA segment related to a gene but nonfunctional due to mutations or lack of regulatory elements. RPSAP70 is a nonfunctional pseudogene and not a valid therapeutic target. Information on RPSA functions or disease associations does not apply to RPSAP70.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 70 (RPSAP70).